I haven't seen anything positive about those drugs in COVID-19 in human patients. For example, the RECOVERY trial showed no benefit (and non-significant numerical harm) for HCQ: https://www.nejm.org/doi/10.1056/NEJMoa2022926
I haven't seen anything positive about those drugs in COVID-19 in human patients. For example, the RECOVERY trial showed no benefit (and non-significant numerical harm) for HCQ: https://www.nejm.org/doi/10.1056/NEJMoa2022926
The RECOVERY results for HCQ were definitely negative. Personally I'm neutral on its effectiveness, but HCQ proponents would probably say that HCQ's postulated antiviral mechanism is not effective on already hospitalized patients, since most of them would have already cleared the virus by the time they showed up to the hospital.
https://twitter.com/AbdenurFlavio/status/1398717229366235141
This expose on the suppression of ivermectin is telling: https://covid19criticalcare.com/wp-content/uploads/2021/05/T...
Lots of studies referenced in it.